Cavu Advisors, LLC, 10% Owner at Lantern Pharma Inc. (LTRN), sold 43,888 shares at $6.33 ($277K) on 2024-05-24, disclosed to the SEC on 2024-05-28.
Open-market sale of $277k LTRN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.25 | 930 | $6K | 2.1% |
| 2 | $6.25 | 2,126 | $13K | 4.8% |
| 3 | $6.25 | 6,944 | $43K | 15.7% |
| 4 | $6.33 | 1,859 | $12K | 4.2% |
| 5 | $6.33 | 4,253 | $27K | 9.7% |
| 6 | $6.33 | 13,888 |
| $88K |
| 31.7% |
| 7 | $6.33 | 13,888 | $88K | 31.7% |
| Total | $6.31 avg | 43,888 | $277K | 100% |
| Filing → |
| AZTR | BUY | 2023-06-23 | $3.0M | — | Filing → |
| INAB | BUY | 2022-08-30 | $165K | — | Filing → |